Hyro Raises $45 Million to Accelerate AI Agents for Healthcare
Hyro secures a $45 M strategic growth investment to scale its healthcare-native AI agent platform — aiming to streamline patient access, automate workflows and relieve overstretched health systems.
TL;DR
Hyro has raised $45 million in new funding, doubling its valuation and bringing total funding to $95 million. Led by Healthier Capital and supported by strategic investors including Bon Secours Mercy Health and ServiceNow Ventures, the round will fuel growth of Hyro’s administrative, operational and clinical AI agents across voice, chat and digital channels in the U.S. healthcare system. The company claims its platform can resolve up to 85 % of routine patient interactions and is already in use at more than 45 health systems.
Hyro just pulled off a significant milestone in the healthcare tech world — raising $45 million to ramp up its AI agent platform built specifically for providers and patients. The funding round was led by Healthier Capital, alongside seasoned investors and strategic partners. With this injection of capital, Hyro’s total funding now sits around $95 million.
So what does Hyro actually do?
At its core, Hyro builds conversational-AI “agents” that live in hospitals’ websites, apps, and call-centres. These agents are designed for tasks like scheduling appointments, handling registration, prescription refills, and directing patient queries — automating up to 85 % of routine interactions according to the company.What makes this especially interesting is how the platform is built for healthcare: deep integrations with electronic health records (EHRs), CRM systems, voice + chat channels — plus the compliance needed in a regulated space.
Why now matters ?
Healthcare systems are under pressure: overloaded staff, rising demand for digitally safe and efficient interactions, and patient expectations for “instant” answers. Hyro says its tech is already deployed across 45+ major U.S. health systems, serving over 30 million patients.The fresh funding will fuel deeper expansion: more features, more specialties, more healthcare segments.
“After another 10 months of strong execution, landing new enterprise customers and expanding relationships with existing ones, we decided to bring on additional capital to further our mission of improving patient access to care and driving operational excellence for health systems…” — Israel Krush, CEO & Co-Founder of Hyro
This gives a clear window into the mindset: Hyro sees itself not just as creating chatbots, but as creating enterprise-grade AI agents built for real world healthcare workflows.
What makes Hyro stand out
Lots of AI startups talk about generative tech or chatbots. Hyro emphasizes that its difference lies in being healthcare-native. The agents are built with compliance, deep integrations, and domain knowledge. The quote above and other commentary point to the belief that success in this space isn’t just a fancy demo — it’s about “patient-ready” and “enterprise-ready.”
What’s next
The next big test for Hyro will be scaling responsibly — making sure the tech stays safe, accurate, and interoperable as more hospitals plug it in. If they get it right, Hyro could set the standard for how AI actually fits into real healthcare operations — not as a novelty, but as everyday infrastructure.
